Autres langues Annexon, Inc.

Actions

ANNX

US03589W1027

Marché Fermé - Nasdaq Autres places de cotation 22:00:01 01/05/2024			Varia. 5j.	Varia. 1 janv.
4,745 ^USD	+4,29 %		+6,63 %	+4,52 %

01/04	ANNEXON, INC. : JPMorgan Chase favorable sur le dossier	ZM
27/03	ANNEXON, INC. : Wells Fargo Securities toujours positif	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting	01/05
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting	01/05
ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(4)	17/04
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)	16/04
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	03/04
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	03/04
Annexon Q4 Loss Narrows	26/03
Annexon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones	26/03
Annexon, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)	18/03
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	15/03
North American Morning Briefing : Stock Futures -2-	04/03
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	27/02
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	27/02
ANNEXON REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)	21/02
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach	21/02
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach	21/02
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)	20/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Annexon, Inc.

Actions

ANNX

US03589W1027

Autres langues

Filtres